Help us revolutionize the way drugs are discovered & developed! Currently, it takes on average 12 years and $2.6 billion to get a single drug to market, with the drug discovery and development process costing $1.4 billion. Last year, Verge Genomics raised $32 million in Series A financing to change this broken model by fueling the drug discovery pipeline with machine learning. Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases. Our platform uses patient genomes, gene expression, and epigenomics to identify new therapeutic gene targets, predict effective drugs, and stratify patient subpopulations for increased clinical success. Verge's approach offers a breakthrough opportunity to identify drugs that dramatically improve patient outcomes and fundamentally lower the cost curve of pharmaceutical development. We are looking for extraordinary individuals to join our motivated team in taking on our generation's biggest healthcare challenges: ALS, Parkinson's Disease, and Alzheimer's Disease. Our employees are our most important asset; we are a team of founders, excited to learn, roll up our sleeves, and make a real impact. The startup nature of Verge Genomics provides multiple growth opportunities into other areas of the company. As one of the early employees at Verge, your work will have a direct impact on the foundation of a groundbreaking new drug development model. In addition to competitive compensation and benefits, we offer perks like unlimited vacation/sick days, on-site gym access, and free lunch. Verge actively seeks a diverse applicant pool in order to build the strongest possible workforce. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

When kids learn to read on time their opportunities in school and life improve profoundly. If a child cannot read by the time they are in third grade, they are four times less likely to graduate high school.* In 2022, only 33% of U.S. fourth graders and 31% of eighth graders were reading at grade level (National Assessment of Educational Progress reading assessment scores). Ignite! Reading is on a mission to fix this. Ignite partners with schools and districts nationally to provide K-8 students reading instruction grounded in the Science of Reading. Schools in the Ignite program receive a dedicated team of virtual tutors who are highly trained in an evidence-based foundational reading skills curriculum rooted in the Science of Reading. Tutors meet virtually each day with students in targeted 1:1, 15-minute sessions. Baseline assessments and data from routine progress monitoring give tutors insight into decoding gaps, allowing them to tailor lessons to each student’s specific needs as a developing reader. Tutoring happens during the school day and can seamlessly fit into a school’s literacy block. Ignite’s results speak for themselves. During the 2021-2022 school year, students in the Ignite program made 2.4 weeks of reading progress for every week in the program. Those same results held true for students of color, white students, multilingual learners, students with IEPs, and those receiving free and reduced lunch. “I haven’t seen anything as simple or effective in a while. It’s such an innovative, promising approach to closing the achievement gap. I’m really excited about it.” - Assistant Superintendent, Worcester, MA *Double Jeopardy: How Third-Grade Reading Skills and Poverty Influence High School Graduation